Skip to main content

Advertisement

Log in

Appropriateness of Laboratory Testing in Inflammatory Bowel Disease Inpatients: An Opportunity to Reduce Unnecessary Healthcare Costs

  • Brief Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bassi A, et al. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut. 2004;53(10):1471–1478.

    Article  CAS  PubMed  Google Scholar 

  2. Thorpe KE. The rise in health care spending and what to do about it. Health Aff (Millwood). 2005;24(6):1436–1445.

    Article  Google Scholar 

  3. Thorpe KE et al. The rising prevalence of treated disease: effects on private health insurance spending. Health Aff (Millwood); 2005. Suppl Web Exclusives: W5-317–W5-325.

  4. Park KT, Bass, D. Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review. Inflamm Bowel Dis. 2011;17(7):1603–1609.

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aoibhlinn O’Toole.

Rights and permissions

Reprints and permissions

About this article

Cite this article

O’Toole, A., Harewood, G.C. Appropriateness of Laboratory Testing in Inflammatory Bowel Disease Inpatients: An Opportunity to Reduce Unnecessary Healthcare Costs. Dig Dis Sci 59, 295–296 (2014). https://doi.org/10.1007/s10620-013-2910-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-013-2910-8

Keywords

Navigation